The global cytogenetic systems industry is set to witness an exceptional surge, projecting an anticipated valuation of US$ 5,327.8 Million by 2032, marking a substantial growth from its estimated worth of US$ 1,688.5 Million in 2022. This exponential expansion, projected at a remarkable CAGR of 11.0%, is attributed to several pivotal factors driving advancements in genetic research and diagnostics.
The surge in demand for cytogenetic systems stems from the pressing need to address the rising incidence of genetic disorders and cancer worldwide. With an increasing prevalence of these conditions, the significance of cytogenetic systems in accurate diagnosis, prognosis, and personalized treatment strategies becomes ever more crucial.
To Get the Sample Copy of Report Visit! https://www.futuremarketinsights.com/reports/sample/rep-gb-4208
In addition to the diagnosis of disease, cytogenetics involve applications such as gene mapping, marker chromosome identification, total chromosome analysis, translocation analysis, unique sequence DNA detection, microdeletion syndrome analysis and gene amplification analysis.
Cytogenetic systems industry: Drivers and Restraints
The key contributor to the growth of global Cytogenetic systems industry is rising demand of early diagnosis of severe life threatening diseases such as cancer and diagnosis of disorders due to chromosomal anomalies in developing embryos. Moreover, expansion of geriatric population pool, rising exposure to dangerous chemicals and ultraviolet rays, increase in numbers of people adopting bad habits such as smoking and drinking and the sedentary lifestyle is fuelling the market growth.
There are some factors which may slow down the market growth rate including technical limitations and complexities associated with the equipment, lack of awareness about advanced technological methodologies especially in low and middle income countries and high cost of sophisticated devices.
Cytogenetic systems industry: Overview
Global cytogenetic systems industry is highly fragmented with the presence of multiple players. Several collaborations and acquisitions focused on cytogenetic products have been reported recently such as Biological Industries USA, Inc. (BIUSA) collaborated with Rainbow Scientific, Inc. to co-promote and sell BI-USA’s range of cytogenetic products, Roche and PerkinElmer entered into a new agreement for distribution of a PerkinElmer’s cytogenetic system and BioDot and ADS Biotech teamed up to market the Cell Writer Workstation in Europe.
Reach Out To Our Analyst And Get All Your Queries Answered! https://www.futuremarketinsights.com/ask-question/rep-gb-4208
According to the WHO data, around 250,000 families in the USA are affected by Down syndrome, 20-30% of all infant deaths across the globe are due to genetic disorders and 30-50% of post-neonatal deaths are due to congenital malformations.
According to the statistics of the International Agency for Research on Cancer (IARC), in 2012, around 14.1 million new cancer cases and 8.2 million cancer deaths were reported worldwide. The numbers of new cancer cases and deaths due to cancers are expected to grow to 21.7 million and 13 million by 2030. The future burden may be even larger because of the adoption of sedentary lifestyles and bad habits such as smoking, poor diet, physical inactivity in developing countries.
Cytogenetic systems industry: Key Players
Some of the players in the global Cytogenetic systems industry include ADS Biotec Inc., Genial Genetics, Laboratory Imaging s.r.o., MetaSystems, Agilent Technologies, Cytocell Ltd, Leica Biosystems Nussloch GmbH, Applied Spectral Imaging, Irvine Scientific, PerkinElmer Inc., Bio-Rad Laboratories, Inc. and Abbott Laboratories.
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
Art of Personalization: Dive into the World of Customization with Our Report! https://www.futuremarketinsights.com/customization-available/rep-gb-4208
Cytogenetic systems industry: Segmentation
Global Cytogenetic systems industry has been segmented on the basis of technologies, applications, end users and region.
Based on technologies, the global Cytogenetic systems industry is segmented into:
- Flow cytometry
- Fluorescence In Situ Hybridization (FISH)
- Multiplex- Fluorescence In Situ Hybridization (M-FISH)
- Comparative Genomic Hybridization (CGH)
Based on applications, the global cytogenetic systems industry is segmented into:
- Genetic Disorders
- Neoplastic Diseases
- Personalized Medicine
- Others
Based on end users, the global Cytogenetic systems industry is segmented into:
- Hospitals
- Clinics
- Diagnostic Laboratory Centers
- Research Institutes
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube